Pathophysiological Roles of the TRPV4 Channel in the Heart
Cells · 17.06.2023 · 12 (12) · 1654
DOI: 10.3390/cells12121654 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 17.06.2023. Verfasst von Sébastien Chaigne und 4 weiteren Autor:innen. Beteiligte Einrichtung: IHU LIRYC Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, 33600 Bordeaux, France. Hauptthemen laut MEDLINE: Transient Receptor Potential Channels, Myocardial Infarction. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Agency, French ANR CANALBRET, New Aquitaine regional council PHYSTRIG.
Abstract (Originalsprache)
The transient receptor potential vanilloid 4 (TRPV4) channel is a non-selective cation channel that is mostly permeable to calcium (Ca2+), which participates in intracellular Ca2+ handling in cardiac cells. It is widely expressed through the body and is activated by a large spectrum of physicochemical stimuli, conferring it a role in a variety of sensorial and physiological functions. Within the cardiovascular system, TRPV4 expression is reported in cardiomyocytes, endothelial cells (ECs) and smooth muscle cells (SMCs), where it modulates mitochondrial activity, Ca2+ homeostasis, cardiomyocytes electrical activity and contractility, cardiac embryonic development and fibroblast proliferation, as well as vascular permeability, dilatation and constriction. On the other hand, TRPV4 channels participate in several cardiac pathological processes such as the development of cardiac fibrosis, hypertrophy, ischemia–reperfusion injuries, heart failure, myocardial infarction and arrhythmia. In this manuscript, we provide an overview of TRPV4 channel implications in cardiac physiology and discuss the potential of the TRPV4 channel as a therapeutic target against cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IHU LIRYC Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, 33600 Bordeaux, France.
- Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, University of Bordeaux, 33600 Pessac, France.
- Electrophysiology and Ablation Unit, Bordeaux University Hospital, 33604 Pessac, France.
- UR4650, Physiopathologie et Stratégies d'Imagerie du Remodelage Cardiovasculaire, GIP Cyceron, Université de Caen Normandie, 14032 Caen, France.
ORCID-Profile: Sébastien Chaigne, Thomas Ducret, David Benoist
Förderung
- National Research Agency
- French ANR CANALBRET
- New Aquitaine regional council PHYSTRIG
- ANR MEGAVOLT
Zitieren
APA
Chaigne, S., Barbeau, S., Ducret, T., Guinamard, R., & Benoist, D. (2023). Pathophysiological Roles of the TRPV4 Channel in the Heart. Cells, 12(12), 1654. https://doi.org/10.3390/cells12121654
Vancouver
Chaigne S, Barbeau S, Ducret T, Guinamard R, Benoist D. Pathophysiological Roles of the TRPV4 Channel in the Heart. Cells. 2023;12(12):1654. doi:10.3390/cells12121654
BibTeX
@article{Chaigne2023,
author = {Chaigne, Sébastien and Barbeau, Solène and Ducret, Thomas and Guinamard, Romain and Benoist, David},
title = {Pathophysiological Roles of the TRPV4 Channel in the Heart},
journal = {Cells},
year = {2023},
volume = {12},
number = {12},
pages = {1654},
doi = {10.3390/cells12121654}
}
EUVIMED